Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Relli V, Trerotola M, Guerra E, et al. Abandoning the notion of non-small cell lung cancer. Trends Mol Med. 2019;25(7):585–594.
   PubMed Web of Science ®Google Scholar
• Cao Q, You X, Xu L, et al. PAQR3 suppresses the growth of non-small cell lung cancer cells via modulation of EGFR-mediated autophagy. Autophagy. 2020;16(7):1236–1247.
   PubMed Web of Science ®Google Scholar
• Tsvetkova E, Goss GD. Drug resistance and its significance for treatment decisions in non-small-cell lung cancer. Curr Oncol. 2012;19(Suppl 1):S45–51.
   PubMedGoogle Scholar
• Zhu R, Xue X, Shen M, et al. NFκB and TNFα as individual key molecules associated with the cisplatin-resistance and radioresistance of lung cancer. Exp Cell Res. 2019;374(1):181–188.
   PubMed Web of Science ®Google Scholar
• Lin C, Xie L, Lu Y, et al. miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells. Int J Mol Med. 2018;41(4):2050–2058.
   PubMed Web of Science ®Google Scholar
• Yébenes H, Mesa P, Muñoz IG, et al. Chaperonins: two rings for folding. Trends Biochem Sci. 2011;36(8):424–432.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Y, Wei Y, et al. Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells. Cancer Lett. 2016;372(1):101–109.
   PubMed Web of Science ®Google Scholar
• Yao L, Zou X, Liu L. The TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma. Int J Clin Exp Pathol. 2019;12(9):3329–3343.
   PubMed Web of Science ®Google Scholar
• Li LJ, Zhang LS, Han ZJ, et al. Chaperonin containing TCP-1 subunit 3 is critical for gastric cancer growth. Oncotarget. 2017;8(67):111470–111481.
   PubMedGoogle Scholar
• Qu H, Zhu F, Dong H, et al. Upregulation of CCT-3 induces breast cancer cell proliferation through miR-223 competition and Wnt/β-catenin signaling pathway activation. Front Oncol. 2020;10:533176.
   PubMed Web of Science ®Google Scholar
• Guanizo AC, Fernando CD, Garama DJ, et al. STAT3: a multifaceted oncoprotein. Growth Factors. 2018;36(1–2):1–14.
   PubMed Web of Science ®Google Scholar
• You L, Wang Z, Li H, et al. The role of STAT3 in autophagy. Autophagy. 2015;11(5):729–739.
   PubMed Web of Science ®Google Scholar
• Hou J, Lv A, Deng Q, et al. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway. Oncol Rep. 2019;41(2):753–764.
   PubMed Web of Science ®Google Scholar
• Wörmann SM, Song L, Ai J, et al. Loss of P53 function activates JAK2-STAT3 signaling to promote pancreatic tumor growth, stroma modification, and gemcitabine resistance in mice and is associated with patient survival. Gastroenterology. 2016;151(1):180–193.e112.
   PubMed Web of Science ®Google Scholar
• Zhu X, Liu L, Wang Y, et al. lncRNA MIAT/HMGB1 axis is involved in cisplatin resistance via regulating IL6-mediated activation of the JAK2/STAT3 pathway in nasopharyngeal carcinoma. Front Oncol. 2021;11:651693.
   PubMed Web of Science ®Google Scholar
• Zhang W, Qiao B, Fan J. Overexpression of miR-4443 promotes the resistance of non-small cell lung cancer cells to epirubicin by targeting INPP4A and regulating the activation of JAK2/STAT3 pathway. Pharmazie. 2018;73(7):386–392.
   PubMed Web of Science ®Google Scholar
• Qian T, Cui L, Liu Y, et al. High expression of chaperonin-containing TCP1 subunit 3 may induce dismal prognosis in multiple myeloma. Pharmacogenomics J. 2020;20(4):563–573.
   PubMed Web of Science ®Google Scholar
• Kasembeli M, Lau WC, Roh SH, et al. Modulation of STAT3 folding and function by TRiC/CCT chaperonin. PLoS Biol. 2014;12(4):e1001844.
   PubMed Web of Science ®Google Scholar
• Ge P, Cao L, Yao YJ, et al. lncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR185-5p-SIX1 axis. Onco Targets Ther. 2019;12:6105–6117.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–w102.
   PubMed Web of Science ®Google Scholar
• Teng X, Fan XF, Li Q, et al. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells. Oncol Rep. 2019;41(3):1875–1882.
   PubMed Web of Science ®Google Scholar
• Li J, Liu X, Li C, et al. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma. J Cell Biochem. 2019;120(8):12412–12421.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhang Z, Xu H, et al. Lidocaine alleviates cytotoxicity-resistance in lung cancer A549/DDP cells via down-regulation of miR-21. Mol Cell Biochem. 2019;456(1–2):63–72.
   PubMed Web of Science ®Google Scholar
• Xu G, Bu S, Wang X, et al. Suppression of CCT3 inhibits the proliferation and migration in breast cancer cells. Cancer Cell Int. 2020;20:218.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Wang LH. FARP1 facilitates cell proliferation through modulating MAPK signaling pathway in cutaneous melanoma. Am J Dermatopathol. 2019;41(12):908–913.
   PubMed Web of Science ®Google Scholar
• Chen H, Li M, Huang P. LncRNA SNHG16 promotes hepatocellular carcinoma proliferation, migration and invasion by regulating miR-186 expression. J Cancer. 2019;10(15):3571–3581.
   PubMed Web of Science ®Google Scholar
• Feng L, Ma J, Ji H, et al. miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5. Biosci Rep. 2017;37(3). DOI:10.1042/BSR20170019
   Web of Science ®Google Scholar
• Yan S, Tang Z, Chen K, et al. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression. J Exp Clin Cancer Res. 2018;37(1):214.
   PubMedGoogle Scholar
• Pan X, Chen Y, Shen Y, et al. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7. Cell Death Dis. 2019;10(6):429.
   PubMedGoogle Scholar
• Liu Y, Zhang X, Lin J, et al. CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. Cell Death Dis. 2019;10(9):644.
   PubMedGoogle Scholar
• Shi X, Cheng S, Wang W. Suppression of CCT3 inhibits malignant proliferation of human papillary thyroid carcinoma cell. Oncol Lett. 2018;15(6):9202–9208.
   PubMed Web of Science ®Google Scholar
• Ooe A, Kato K, Noguchi S. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers. Breast Cancer Res Treat. 2007;101(3):305–315.
   PubMed Web of Science ®Google Scholar
• Yang X, Ren H, Shao Y, et al. Chaperonin-containing T‑complex protein 1 subunit 8 promotes cell migration and invasion in human esophageal squamous cell carcinoma by regulating α-actin and β-tubulin expression. Int J Oncol. 2018;52(6):2021–2030.
   PubMed Web of Science ®Google Scholar
• Keenan J, Murphy L, Henry M, et al. Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line. Proteomics. 2009;9(6):1556–1566.
   PubMed Web of Science ®Google Scholar
• Lee MH, Cho Y, Kim DH, et al. Menadione induces G2/M arrest in gastric cancer cells by down-regulation of CDC25C and proteasome mediated degradation of CDK1 and cyclin B1. Am J Transl Res. 2016;8(12):5246–5255.
   PubMed Web of Science ®Google Scholar
• Cui X, Hu ZP, Li Z, et al. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma. World J Gastroenterol. 2015;21(28):8588–8604.
   PubMed Web of Science ®Google Scholar
• Nakamura T. Shadow cell differentiation: a comparative analysis of modes of cell death with apoptosis and epidermal/trichilemmal keratinization. Dermatopathology (Basel). 2018;5(3):86–97.
   PubMed Web of Science ®Google Scholar
• Hu Y, Hong Y, Xu Y, et al. Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC. Apoptosis. 2014;19(11):1627–1636.
   PubMed Web of Science ®Google Scholar
• Park JS, Lee J, Lim MA, et al. JAK2-STAT3 blockade by AG490 suppresses autoimmune arthritis in mice via reciprocal regulation of regulatory T cells and Th17 cells. J Immunol. 2014;192(9):4417–4424.
   PubMed Web of Science ®Google Scholar
• Kim BI, Kim JH, Sim DY, et al. Inhibition of JAK2/STAT3 and activation of caspase‑9/3 are involved in KYS05090S‑induced apoptosis in ovarian cancer cells. Int J Oncol. 2019;55(1):203–210.
   PubMed Web of Science ®Google Scholar